Global Tumor NGS Genetic Testing Supply, Demand and Key Producers, 2023-2029
The global Tumor NGS Genetic Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
This report studies the global Tumor NGS Genetic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor NGS Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor NGS Genetic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor NGS Genetic Testing total market, 2018-2029, (USD Million)
Global Tumor NGS Genetic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor NGS Genetic Testing total market, key domestic companies and share, (USD Million)
Global Tumor NGS Genetic Testing revenue by player and market share 2018-2023, (USD Million)
Global Tumor NGS Genetic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor NGS Genetic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Tumor NGS Genetic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc. and Amoy Diagnostics Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor NGS Genetic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor NGS Genetic Testing Market, By Region:
1. How big is the global Tumor NGS Genetic Testing market?
2. What is the demand of the global Tumor NGS Genetic Testing market?
3. What is the year over year growth of the global Tumor NGS Genetic Testing market?
4. What is the total value of the global Tumor NGS Genetic Testing market?
5. Who are the major players in the global Tumor NGS Genetic Testing market?
6. What are the growth factors driving the market demand?
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
This report studies the global Tumor NGS Genetic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor NGS Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor NGS Genetic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor NGS Genetic Testing total market, 2018-2029, (USD Million)
Global Tumor NGS Genetic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor NGS Genetic Testing total market, key domestic companies and share, (USD Million)
Global Tumor NGS Genetic Testing revenue by player and market share 2018-2023, (USD Million)
Global Tumor NGS Genetic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor NGS Genetic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Tumor NGS Genetic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc. and Amoy Diagnostics Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor NGS Genetic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor NGS Genetic Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Liquid Biopsy (Blood Sample)
- Tissue Biopsy
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Foundation Medicine
- Guardant Health
- Illumina
- Thermo Fisher Scientific Inc.
- DIAN DIAGNOSTICS Group Co., Ltd.
- Burning Rock Biotech.
- NovogeneCo.,Ltd.
- Nanjing Shihejiyin Technology, Inc.
- Amoy Diagnostics Co.,Ltd.
- China National Pharmaceutical Group Corporation
- Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- Guangzhou Kingmed Diagnostics Group Co.,Ltd.
- ADICON Clinical Laboratories, Inc.
- Genetron
- Genecast Group Inc.
- BGI Genomics Co.,Ltd.
- Beijing-Geneplus Technology Limited.
- Xiamen SpacegenCo., Ltd.
- Geneis?Beijing?Co.Ltd.
- HaploX
1. How big is the global Tumor NGS Genetic Testing market?
2. What is the demand of the global Tumor NGS Genetic Testing market?
3. What is the year over year growth of the global Tumor NGS Genetic Testing market?
4. What is the total value of the global Tumor NGS Genetic Testing market?
5. Who are the major players in the global Tumor NGS Genetic Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tumor NGS Genetic Testing Introduction
1.2 World Tumor NGS Genetic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor NGS Genetic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Tumor NGS Genetic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.3 China Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.4 Europe Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.5 Japan Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.6 South Korea Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.7 ASEAN Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.8 India Tumor NGS Genetic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor NGS Genetic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor NGS Genetic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.2 World Tumor NGS Genetic Testing Consumption Value by Region
2.2.1 World Tumor NGS Genetic Testing Consumption Value by Region (2018-2023)
2.2.2 World Tumor NGS Genetic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.4 China Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.5 Europe Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.6 Japan Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.7 South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.8 ASEAN Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.9 India Tumor NGS Genetic Testing Consumption Value (2018-2029)
3 WORLD TUMOR NGS GENETIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor NGS Genetic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor NGS Genetic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor NGS Genetic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor NGS Genetic Testing in 2022
3.3 Tumor NGS Genetic Testing Company Evaluation Quadrant
3.4 Tumor NGS Genetic Testing Market: Overall Company Footprint Analysis
3.4.1 Tumor NGS Genetic Testing Market: Region Footprint
3.4.2 Tumor NGS Genetic Testing Market: Company Product Type Footprint
3.4.3 Tumor NGS Genetic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor NGS Genetic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor NGS Genetic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor NGS Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor NGS Genetic Testing Consumption Value Comparison
4.2.1 United States VS China: Tumor NGS Genetic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor NGS Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor NGS Genetic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
4.4 China Based Companies Tumor NGS Genetic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor NGS Genetic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
4.5 Rest of World Based Tumor NGS Genetic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor NGS Genetic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Liquid Biopsy (Blood Sample)
5.2.2 Tissue Biopsy
5.3 Market Segment by Type
5.3.1 World Tumor NGS Genetic Testing Market Size by Type (2018-2023)
5.3.2 World Tumor NGS Genetic Testing Market Size by Type (2024-2029)
5.3.3 World Tumor NGS Genetic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor NGS Genetic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Companion Diagnostics
6.2.2 Early Cancer Screening
6.2.3 Drug Discovery
6.3 Market Segment by Application
6.3.1 World Tumor NGS Genetic Testing Market Size by Application (2018-2023)
6.3.2 World Tumor NGS Genetic Testing Market Size by Application (2024-2029)
6.3.3 World Tumor NGS Genetic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Foundation Medicine
7.1.1 Foundation Medicine Details
7.1.2 Foundation Medicine Major Business
7.1.3 Foundation Medicine Tumor NGS Genetic Testing Product and Services
7.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Foundation Medicine Recent Developments/Updates
7.1.6 Foundation Medicine Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Tumor NGS Genetic Testing Product and Services
7.2.4 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Tumor NGS Genetic Testing Product and Services
7.3.4 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Details
7.4.2 Thermo Fisher Scientific Inc. Major Business
7.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Services
7.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.5 DIAN DIAGNOSTICS Group Co., Ltd.
7.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Details
7.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Major Business
7.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Services
7.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments/Updates
7.5.6 DIAN DIAGNOSTICS Group Co., Ltd. Competitive Strengths & Weaknesses
7.6 Burning Rock Biotech.
7.6.1 Burning Rock Biotech. Details
7.6.2 Burning Rock Biotech. Major Business
7.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Product and Services
7.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Burning Rock Biotech. Recent Developments/Updates
7.6.6 Burning Rock Biotech. Competitive Strengths & Weaknesses
7.7 NovogeneCo.,Ltd.
7.7.1 NovogeneCo.,Ltd. Details
7.7.2 NovogeneCo.,Ltd. Major Business
7.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Services
7.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 NovogeneCo.,Ltd. Recent Developments/Updates
7.7.6 NovogeneCo.,Ltd. Competitive Strengths & Weaknesses
7.8 Nanjing Shihejiyin Technology, Inc.
7.8.1 Nanjing Shihejiyin Technology, Inc. Details
7.8.2 Nanjing Shihejiyin Technology, Inc. Major Business
7.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Services
7.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Nanjing Shihejiyin Technology, Inc. Recent Developments/Updates
7.8.6 Nanjing Shihejiyin Technology, Inc. Competitive Strengths & Weaknesses
7.9 Amoy Diagnostics Co.,Ltd.
7.9.1 Amoy Diagnostics Co.,Ltd. Details
7.9.2 Amoy Diagnostics Co.,Ltd. Major Business
7.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Amoy Diagnostics Co.,Ltd. Recent Developments/Updates
7.9.6 Amoy Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
7.10 China National Pharmaceutical Group Corporation
7.10.1 China National Pharmaceutical Group Corporation Details
7.10.2 China National Pharmaceutical Group Corporation Major Business
7.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Services
7.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 China National Pharmaceutical Group Corporation Recent Developments/Updates
7.10.6 China National Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
7.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
7.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details
7.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
7.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
7.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details
7.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
7.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments/Updates
7.12.6 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Competitive Strengths & Weaknesses
7.13 ADICON Clinical Laboratories, Inc.
7.13.1 ADICON Clinical Laboratories, Inc. Details
7.13.2 ADICON Clinical Laboratories, Inc. Major Business
7.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Services
7.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ADICON Clinical Laboratories, Inc. Recent Developments/Updates
7.13.6 ADICON Clinical Laboratories, Inc. Competitive Strengths & Weaknesses
7.14 Genetron
7.14.1 Genetron Details
7.14.2 Genetron Major Business
7.14.3 Genetron Tumor NGS Genetic Testing Product and Services
7.14.4 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Genetron Recent Developments/Updates
7.14.6 Genetron Competitive Strengths & Weaknesses
7.15 Genecast Group Inc.
7.15.1 Genecast Group Inc. Details
7.15.2 Genecast Group Inc. Major Business
7.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Product and Services
7.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genecast Group Inc. Recent Developments/Updates
7.15.6 Genecast Group Inc. Competitive Strengths & Weaknesses
7.16 BGI Genomics Co.,Ltd.
7.16.1 BGI Genomics Co.,Ltd. Details
7.16.2 BGI Genomics Co.,Ltd. Major Business
7.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BGI Genomics Co.,Ltd. Recent Developments/Updates
7.16.6 BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
7.17 Beijing-Geneplus Technology Limited.
7.17.1 Beijing-Geneplus Technology Limited. Details
7.17.2 Beijing-Geneplus Technology Limited. Major Business
7.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Services
7.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Beijing-Geneplus Technology Limited. Recent Developments/Updates
7.17.6 Beijing-Geneplus Technology Limited. Competitive Strengths & Weaknesses
7.18 Xiamen SpacegenCo., Ltd.
7.18.1 Xiamen SpacegenCo., Ltd. Details
7.18.2 Xiamen SpacegenCo., Ltd. Major Business
7.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Services
7.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Xiamen SpacegenCo., Ltd. Recent Developments/Updates
7.18.6 Xiamen SpacegenCo., Ltd. Competitive Strengths & Weaknesses
7.19 Geneis?Beijing?Co.Ltd.
7.19.1 Geneis?Beijing?Co.Ltd. Details
7.19.2 Geneis?Beijing?Co.Ltd. Major Business
7.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Services
7.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Geneis?Beijing?Co.Ltd. Recent Developments/Updates
7.19.6 Geneis?Beijing?Co.Ltd. Competitive Strengths & Weaknesses
7.20 HaploX
7.20.1 HaploX Details
7.20.2 HaploX Major Business
7.20.3 HaploX Tumor NGS Genetic Testing Product and Services
7.20.4 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 HaploX Recent Developments/Updates
7.20.6 HaploX Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor NGS Genetic Testing Industry Chain
8.2 Tumor NGS Genetic Testing Upstream Analysis
8.3 Tumor NGS Genetic Testing Midstream Analysis
8.4 Tumor NGS Genetic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tumor NGS Genetic Testing Introduction
1.2 World Tumor NGS Genetic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor NGS Genetic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Tumor NGS Genetic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.3 China Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.4 Europe Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.5 Japan Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.6 South Korea Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.7 ASEAN Tumor NGS Genetic Testing Market Size (2018-2029)
1.3.8 India Tumor NGS Genetic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor NGS Genetic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor NGS Genetic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.2 World Tumor NGS Genetic Testing Consumption Value by Region
2.2.1 World Tumor NGS Genetic Testing Consumption Value by Region (2018-2023)
2.2.2 World Tumor NGS Genetic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.4 China Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.5 Europe Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.6 Japan Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.7 South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.8 ASEAN Tumor NGS Genetic Testing Consumption Value (2018-2029)
2.9 India Tumor NGS Genetic Testing Consumption Value (2018-2029)
3 WORLD TUMOR NGS GENETIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor NGS Genetic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor NGS Genetic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor NGS Genetic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor NGS Genetic Testing in 2022
3.3 Tumor NGS Genetic Testing Company Evaluation Quadrant
3.4 Tumor NGS Genetic Testing Market: Overall Company Footprint Analysis
3.4.1 Tumor NGS Genetic Testing Market: Region Footprint
3.4.2 Tumor NGS Genetic Testing Market: Company Product Type Footprint
3.4.3 Tumor NGS Genetic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor NGS Genetic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor NGS Genetic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor NGS Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor NGS Genetic Testing Consumption Value Comparison
4.2.1 United States VS China: Tumor NGS Genetic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor NGS Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor NGS Genetic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
4.4 China Based Companies Tumor NGS Genetic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor NGS Genetic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
4.5 Rest of World Based Tumor NGS Genetic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor NGS Genetic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Liquid Biopsy (Blood Sample)
5.2.2 Tissue Biopsy
5.3 Market Segment by Type
5.3.1 World Tumor NGS Genetic Testing Market Size by Type (2018-2023)
5.3.2 World Tumor NGS Genetic Testing Market Size by Type (2024-2029)
5.3.3 World Tumor NGS Genetic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor NGS Genetic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Companion Diagnostics
6.2.2 Early Cancer Screening
6.2.3 Drug Discovery
6.3 Market Segment by Application
6.3.1 World Tumor NGS Genetic Testing Market Size by Application (2018-2023)
6.3.2 World Tumor NGS Genetic Testing Market Size by Application (2024-2029)
6.3.3 World Tumor NGS Genetic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Foundation Medicine
7.1.1 Foundation Medicine Details
7.1.2 Foundation Medicine Major Business
7.1.3 Foundation Medicine Tumor NGS Genetic Testing Product and Services
7.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Foundation Medicine Recent Developments/Updates
7.1.6 Foundation Medicine Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Tumor NGS Genetic Testing Product and Services
7.2.4 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Tumor NGS Genetic Testing Product and Services
7.3.4 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Details
7.4.2 Thermo Fisher Scientific Inc. Major Business
7.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Services
7.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.5 DIAN DIAGNOSTICS Group Co., Ltd.
7.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Details
7.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Major Business
7.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Services
7.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments/Updates
7.5.6 DIAN DIAGNOSTICS Group Co., Ltd. Competitive Strengths & Weaknesses
7.6 Burning Rock Biotech.
7.6.1 Burning Rock Biotech. Details
7.6.2 Burning Rock Biotech. Major Business
7.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Product and Services
7.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Burning Rock Biotech. Recent Developments/Updates
7.6.6 Burning Rock Biotech. Competitive Strengths & Weaknesses
7.7 NovogeneCo.,Ltd.
7.7.1 NovogeneCo.,Ltd. Details
7.7.2 NovogeneCo.,Ltd. Major Business
7.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Services
7.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 NovogeneCo.,Ltd. Recent Developments/Updates
7.7.6 NovogeneCo.,Ltd. Competitive Strengths & Weaknesses
7.8 Nanjing Shihejiyin Technology, Inc.
7.8.1 Nanjing Shihejiyin Technology, Inc. Details
7.8.2 Nanjing Shihejiyin Technology, Inc. Major Business
7.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Services
7.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Nanjing Shihejiyin Technology, Inc. Recent Developments/Updates
7.8.6 Nanjing Shihejiyin Technology, Inc. Competitive Strengths & Weaknesses
7.9 Amoy Diagnostics Co.,Ltd.
7.9.1 Amoy Diagnostics Co.,Ltd. Details
7.9.2 Amoy Diagnostics Co.,Ltd. Major Business
7.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Amoy Diagnostics Co.,Ltd. Recent Developments/Updates
7.9.6 Amoy Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
7.10 China National Pharmaceutical Group Corporation
7.10.1 China National Pharmaceutical Group Corporation Details
7.10.2 China National Pharmaceutical Group Corporation Major Business
7.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Services
7.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 China National Pharmaceutical Group Corporation Recent Developments/Updates
7.10.6 China National Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
7.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
7.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details
7.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
7.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
7.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details
7.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
7.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments/Updates
7.12.6 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Competitive Strengths & Weaknesses
7.13 ADICON Clinical Laboratories, Inc.
7.13.1 ADICON Clinical Laboratories, Inc. Details
7.13.2 ADICON Clinical Laboratories, Inc. Major Business
7.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Services
7.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ADICON Clinical Laboratories, Inc. Recent Developments/Updates
7.13.6 ADICON Clinical Laboratories, Inc. Competitive Strengths & Weaknesses
7.14 Genetron
7.14.1 Genetron Details
7.14.2 Genetron Major Business
7.14.3 Genetron Tumor NGS Genetic Testing Product and Services
7.14.4 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Genetron Recent Developments/Updates
7.14.6 Genetron Competitive Strengths & Weaknesses
7.15 Genecast Group Inc.
7.15.1 Genecast Group Inc. Details
7.15.2 Genecast Group Inc. Major Business
7.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Product and Services
7.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genecast Group Inc. Recent Developments/Updates
7.15.6 Genecast Group Inc. Competitive Strengths & Weaknesses
7.16 BGI Genomics Co.,Ltd.
7.16.1 BGI Genomics Co.,Ltd. Details
7.16.2 BGI Genomics Co.,Ltd. Major Business
7.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
7.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BGI Genomics Co.,Ltd. Recent Developments/Updates
7.16.6 BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
7.17 Beijing-Geneplus Technology Limited.
7.17.1 Beijing-Geneplus Technology Limited. Details
7.17.2 Beijing-Geneplus Technology Limited. Major Business
7.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Services
7.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Beijing-Geneplus Technology Limited. Recent Developments/Updates
7.17.6 Beijing-Geneplus Technology Limited. Competitive Strengths & Weaknesses
7.18 Xiamen SpacegenCo., Ltd.
7.18.1 Xiamen SpacegenCo., Ltd. Details
7.18.2 Xiamen SpacegenCo., Ltd. Major Business
7.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Services
7.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Xiamen SpacegenCo., Ltd. Recent Developments/Updates
7.18.6 Xiamen SpacegenCo., Ltd. Competitive Strengths & Weaknesses
7.19 Geneis?Beijing?Co.Ltd.
7.19.1 Geneis?Beijing?Co.Ltd. Details
7.19.2 Geneis?Beijing?Co.Ltd. Major Business
7.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Services
7.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Geneis?Beijing?Co.Ltd. Recent Developments/Updates
7.19.6 Geneis?Beijing?Co.Ltd. Competitive Strengths & Weaknesses
7.20 HaploX
7.20.1 HaploX Details
7.20.2 HaploX Major Business
7.20.3 HaploX Tumor NGS Genetic Testing Product and Services
7.20.4 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 HaploX Recent Developments/Updates
7.20.6 HaploX Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor NGS Genetic Testing Industry Chain
8.2 Tumor NGS Genetic Testing Upstream Analysis
8.3 Tumor NGS Genetic Testing Midstream Analysis
8.4 Tumor NGS Genetic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Tumor NGS Genetic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor NGS Genetic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor NGS Genetic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor NGS Genetic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor NGS Genetic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor NGS Genetic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor NGS Genetic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor NGS Genetic Testing Players in 2022
Table 12. World Tumor NGS Genetic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor NGS Genetic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Tumor NGS Genetic Testing Player
Table 15. Tumor NGS Genetic Testing Market: Company Product Type Footprint
Table 16. Tumor NGS Genetic Testing Market: Company Product Application Footprint
Table 17. Tumor NGS Genetic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Tumor NGS Genetic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor NGS Genetic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 23. China Based Tumor NGS Genetic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 29. World Tumor NGS Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor NGS Genetic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor NGS Genetic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor NGS Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor NGS Genetic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor NGS Genetic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Foundation Medicine Basic Information, Area Served and Competitors
Table 36. Foundation Medicine Major Business
Table 37. Foundation Medicine Tumor NGS Genetic Testing Product and Services
Table 38. Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Foundation Medicine Recent Developments/Updates
Table 40. Foundation Medicine Competitive Strengths & Weaknesses
Table 41. Guardant Health Basic Information, Area Served and Competitors
Table 42. Guardant Health Major Business
Table 43. Guardant Health Tumor NGS Genetic Testing Product and Services
Table 44. Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Guardant Health Recent Developments/Updates
Table 46. Guardant Health Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Tumor NGS Genetic Testing Product and Services
Table 50. Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Inc. Major Business
Table 55. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Services
Table 56. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 58. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 59. DIAN DIAGNOSTICS Group Co., Ltd. Basic Information, Area Served and Competitors
Table 60. DIAN DIAGNOSTICS Group Co., Ltd. Major Business
Table 61. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Services
Table 62. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments/Updates
Table 64. DIAN DIAGNOSTICS Group Co., Ltd. Competitive Strengths & Weaknesses
Table 65. Burning Rock Biotech. Basic Information, Area Served and Competitors
Table 66. Burning Rock Biotech. Major Business
Table 67. Burning Rock Biotech. Tumor NGS Genetic Testing Product and Services
Table 68. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Burning Rock Biotech. Recent Developments/Updates
Table 70. Burning Rock Biotech. Competitive Strengths & Weaknesses
Table 71. NovogeneCo.,Ltd. Basic Information, Area Served and Competitors
Table 72. NovogeneCo.,Ltd. Major Business
Table 73. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 74. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. NovogeneCo.,Ltd. Recent Developments/Updates
Table 76. NovogeneCo.,Ltd. Competitive Strengths & Weaknesses
Table 77. Nanjing Shihejiyin Technology, Inc. Basic Information, Area Served and Competitors
Table 78. Nanjing Shihejiyin Technology, Inc. Major Business
Table 79. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Services
Table 80. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Nanjing Shihejiyin Technology, Inc. Recent Developments/Updates
Table 82. Nanjing Shihejiyin Technology, Inc. Competitive Strengths & Weaknesses
Table 83. Amoy Diagnostics Co.,Ltd. Basic Information, Area Served and Competitors
Table 84. Amoy Diagnostics Co.,Ltd. Major Business
Table 85. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 86. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Amoy Diagnostics Co.,Ltd. Recent Developments/Updates
Table 88. Amoy Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
Table 89. China National Pharmaceutical Group Corporation Basic Information, Area Served and Competitors
Table 90. China National Pharmaceutical Group Corporation Major Business
Table 91. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Services
Table 92. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. China National Pharmaceutical Group Corporation Recent Developments/Updates
Table 94. China National Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
Table 95. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Basic Information, Area Served and Competitors
Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments/Updates
Table 100. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Competitive Strengths & Weaknesses
Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Basic Information, Area Served and Competitors
Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments/Updates
Table 106. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Competitive Strengths & Weaknesses
Table 107. ADICON Clinical Laboratories, Inc. Basic Information, Area Served and Competitors
Table 108. ADICON Clinical Laboratories, Inc. Major Business
Table 109. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Services
Table 110. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ADICON Clinical Laboratories, Inc. Recent Developments/Updates
Table 112. ADICON Clinical Laboratories, Inc. Competitive Strengths & Weaknesses
Table 113. Genetron Basic Information, Area Served and Competitors
Table 114. Genetron Major Business
Table 115. Genetron Tumor NGS Genetic Testing Product and Services
Table 116. Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Genetron Recent Developments/Updates
Table 118. Genetron Competitive Strengths & Weaknesses
Table 119. Genecast Group Inc. Basic Information, Area Served and Competitors
Table 120. Genecast Group Inc. Major Business
Table 121. Genecast Group Inc. Tumor NGS Genetic Testing Product and Services
Table 122. Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genecast Group Inc. Recent Developments/Updates
Table 124. Genecast Group Inc. Competitive Strengths & Weaknesses
Table 125. BGI Genomics Co.,Ltd. Basic Information, Area Served and Competitors
Table 126. BGI Genomics Co.,Ltd. Major Business
Table 127. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 128. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BGI Genomics Co.,Ltd. Recent Developments/Updates
Table 130. BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
Table 131. Beijing-Geneplus Technology Limited. Basic Information, Area Served and Competitors
Table 132. Beijing-Geneplus Technology Limited. Major Business
Table 133. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Services
Table 134. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Beijing-Geneplus Technology Limited. Recent Developments/Updates
Table 136. Beijing-Geneplus Technology Limited. Competitive Strengths & Weaknesses
Table 137. Xiamen SpacegenCo., Ltd. Basic Information, Area Served and Competitors
Table 138. Xiamen SpacegenCo., Ltd. Major Business
Table 139. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Services
Table 140. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Xiamen SpacegenCo., Ltd. Recent Developments/Updates
Table 142. Xiamen SpacegenCo., Ltd. Competitive Strengths & Weaknesses
Table 143. Geneis?Beijing?Co.Ltd. Basic Information, Area Served and Competitors
Table 144. Geneis?Beijing?Co.Ltd. Major Business
Table 145. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Services
Table 146. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Geneis?Beijing?Co.Ltd. Recent Developments/Updates
Table 148. HaploX Basic Information, Area Served and Competitors
Table 149. HaploX Major Business
Table 150. HaploX Tumor NGS Genetic Testing Product and Services
Table 151. HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Tumor NGS Genetic Testing Upstream (Raw Materials)
Table 153. Tumor NGS Genetic Testing Typical Customers
Table 1. World Tumor NGS Genetic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor NGS Genetic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor NGS Genetic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor NGS Genetic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor NGS Genetic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor NGS Genetic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor NGS Genetic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor NGS Genetic Testing Players in 2022
Table 12. World Tumor NGS Genetic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor NGS Genetic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Tumor NGS Genetic Testing Player
Table 15. Tumor NGS Genetic Testing Market: Company Product Type Footprint
Table 16. Tumor NGS Genetic Testing Market: Company Product Application Footprint
Table 17. Tumor NGS Genetic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Tumor NGS Genetic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor NGS Genetic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 23. China Based Tumor NGS Genetic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor NGS Genetic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor NGS Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor NGS Genetic Testing Revenue Market Share (2018-2023)
Table 29. World Tumor NGS Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor NGS Genetic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor NGS Genetic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor NGS Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor NGS Genetic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor NGS Genetic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Foundation Medicine Basic Information, Area Served and Competitors
Table 36. Foundation Medicine Major Business
Table 37. Foundation Medicine Tumor NGS Genetic Testing Product and Services
Table 38. Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Foundation Medicine Recent Developments/Updates
Table 40. Foundation Medicine Competitive Strengths & Weaknesses
Table 41. Guardant Health Basic Information, Area Served and Competitors
Table 42. Guardant Health Major Business
Table 43. Guardant Health Tumor NGS Genetic Testing Product and Services
Table 44. Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Guardant Health Recent Developments/Updates
Table 46. Guardant Health Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Tumor NGS Genetic Testing Product and Services
Table 50. Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Inc. Major Business
Table 55. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Services
Table 56. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 58. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 59. DIAN DIAGNOSTICS Group Co., Ltd. Basic Information, Area Served and Competitors
Table 60. DIAN DIAGNOSTICS Group Co., Ltd. Major Business
Table 61. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Services
Table 62. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments/Updates
Table 64. DIAN DIAGNOSTICS Group Co., Ltd. Competitive Strengths & Weaknesses
Table 65. Burning Rock Biotech. Basic Information, Area Served and Competitors
Table 66. Burning Rock Biotech. Major Business
Table 67. Burning Rock Biotech. Tumor NGS Genetic Testing Product and Services
Table 68. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Burning Rock Biotech. Recent Developments/Updates
Table 70. Burning Rock Biotech. Competitive Strengths & Weaknesses
Table 71. NovogeneCo.,Ltd. Basic Information, Area Served and Competitors
Table 72. NovogeneCo.,Ltd. Major Business
Table 73. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 74. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. NovogeneCo.,Ltd. Recent Developments/Updates
Table 76. NovogeneCo.,Ltd. Competitive Strengths & Weaknesses
Table 77. Nanjing Shihejiyin Technology, Inc. Basic Information, Area Served and Competitors
Table 78. Nanjing Shihejiyin Technology, Inc. Major Business
Table 79. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Services
Table 80. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Nanjing Shihejiyin Technology, Inc. Recent Developments/Updates
Table 82. Nanjing Shihejiyin Technology, Inc. Competitive Strengths & Weaknesses
Table 83. Amoy Diagnostics Co.,Ltd. Basic Information, Area Served and Competitors
Table 84. Amoy Diagnostics Co.,Ltd. Major Business
Table 85. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 86. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Amoy Diagnostics Co.,Ltd. Recent Developments/Updates
Table 88. Amoy Diagnostics Co.,Ltd. Competitive Strengths & Weaknesses
Table 89. China National Pharmaceutical Group Corporation Basic Information, Area Served and Competitors
Table 90. China National Pharmaceutical Group Corporation Major Business
Table 91. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Services
Table 92. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. China National Pharmaceutical Group Corporation Recent Developments/Updates
Table 94. China National Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
Table 95. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Basic Information, Area Served and Competitors
Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments/Updates
Table 100. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Competitive Strengths & Weaknesses
Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Basic Information, Area Served and Competitors
Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments/Updates
Table 106. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Competitive Strengths & Weaknesses
Table 107. ADICON Clinical Laboratories, Inc. Basic Information, Area Served and Competitors
Table 108. ADICON Clinical Laboratories, Inc. Major Business
Table 109. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Services
Table 110. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ADICON Clinical Laboratories, Inc. Recent Developments/Updates
Table 112. ADICON Clinical Laboratories, Inc. Competitive Strengths & Weaknesses
Table 113. Genetron Basic Information, Area Served and Competitors
Table 114. Genetron Major Business
Table 115. Genetron Tumor NGS Genetic Testing Product and Services
Table 116. Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Genetron Recent Developments/Updates
Table 118. Genetron Competitive Strengths & Weaknesses
Table 119. Genecast Group Inc. Basic Information, Area Served and Competitors
Table 120. Genecast Group Inc. Major Business
Table 121. Genecast Group Inc. Tumor NGS Genetic Testing Product and Services
Table 122. Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genecast Group Inc. Recent Developments/Updates
Table 124. Genecast Group Inc. Competitive Strengths & Weaknesses
Table 125. BGI Genomics Co.,Ltd. Basic Information, Area Served and Competitors
Table 126. BGI Genomics Co.,Ltd. Major Business
Table 127. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Services
Table 128. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BGI Genomics Co.,Ltd. Recent Developments/Updates
Table 130. BGI Genomics Co.,Ltd. Competitive Strengths & Weaknesses
Table 131. Beijing-Geneplus Technology Limited. Basic Information, Area Served and Competitors
Table 132. Beijing-Geneplus Technology Limited. Major Business
Table 133. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Services
Table 134. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Beijing-Geneplus Technology Limited. Recent Developments/Updates
Table 136. Beijing-Geneplus Technology Limited. Competitive Strengths & Weaknesses
Table 137. Xiamen SpacegenCo., Ltd. Basic Information, Area Served and Competitors
Table 138. Xiamen SpacegenCo., Ltd. Major Business
Table 139. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Services
Table 140. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Xiamen SpacegenCo., Ltd. Recent Developments/Updates
Table 142. Xiamen SpacegenCo., Ltd. Competitive Strengths & Weaknesses
Table 143. Geneis?Beijing?Co.Ltd. Basic Information, Area Served and Competitors
Table 144. Geneis?Beijing?Co.Ltd. Major Business
Table 145. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Services
Table 146. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Geneis?Beijing?Co.Ltd. Recent Developments/Updates
Table 148. HaploX Basic Information, Area Served and Competitors
Table 149. HaploX Major Business
Table 150. HaploX Tumor NGS Genetic Testing Product and Services
Table 151. HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Tumor NGS Genetic Testing Upstream (Raw Materials)
Table 153. Tumor NGS Genetic Testing Typical Customers
LIST OF FIGURES
Figure 1. Tumor NGS Genetic Testing Picture
Figure 2. World Tumor NGS Genetic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor NGS Genetic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Tumor NGS Genetic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor NGS Genetic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor NGS Genetic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor NGS Genetic Testing Markets in 2022
Figure 27. United States VS China: Tumor NGS Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor NGS Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor NGS Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor NGS Genetic Testing Market Size Market Share by Type in 2022
Figure 31. Liquid Biopsy (Blood Sample)
Figure 32. Tissue Biopsy
Figure 33. World Tumor NGS Genetic Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor NGS Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor NGS Genetic Testing Market Size Market Share by Application in 2022
Figure 36. Companion Diagnostics
Figure 37. Early Cancer Screening
Figure 38. Drug Discovery
Figure 39. Tumor NGS Genetic Testing Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Tumor NGS Genetic Testing Picture
Figure 2. World Tumor NGS Genetic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor NGS Genetic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor NGS Genetic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor NGS Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Tumor NGS Genetic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor NGS Genetic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor NGS Genetic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor NGS Genetic Testing Markets in 2022
Figure 27. United States VS China: Tumor NGS Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor NGS Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor NGS Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor NGS Genetic Testing Market Size Market Share by Type in 2022
Figure 31. Liquid Biopsy (Blood Sample)
Figure 32. Tissue Biopsy
Figure 33. World Tumor NGS Genetic Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor NGS Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor NGS Genetic Testing Market Size Market Share by Application in 2022
Figure 36. Companion Diagnostics
Figure 37. Early Cancer Screening
Figure 38. Drug Discovery
Figure 39. Tumor NGS Genetic Testing Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
